BLOG

FDA Proposed Rules: Pharma Solutions’ Comment Submission

FDA Proposed Rules: Pharma Solutions’ Comment Submission

FDA Proposed Rules: Pharma Solutions' Comment Submission Preemption Section 585(b): The Proposed Rules suggest that Preemption shall go beyond license requirements and cover standards for Standard Operating Procedures, disciplinary process, recordkeeping requirements,...

read more
Federal Regulation
Changes Rumored to Be on Horizon for DEA Suspicious Orders

DEA SOM 2020 Updates

Over two years in the making, the light at the end of the tunnel is finally in sight – the Drug Enforcement Administration’s (DEA) update to the infamous definition of a “suspicious order” may only be a few months away. In Fall 2017, the DEA drafted proposed an update to “to revise its regulations relating to suspicious orders of controlled substances,” per RIN 1117-AB47. The new rule will also further specify “the procedures a registrant must follow upon receiving such orders.”

read more

Email Newsletter